1-9 of 9
Nicholas Ramscar
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

ASC4FIRST: A Phase III Study of Asciminib vs Investigator-Selected Tyrosine Kinase Inhibitor in Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

Timothy Hughes, Jorge E. Cortes, Naoto Takahashi, Richard A. Larson, Ghayas C. Issa, Felice Bombaci, Nicholas Ramscar, Shruti Kapoor, Sophie Ifrah, Andreas Hochhaus
Journal: Blood
Blood (2022) 140 (Supplement 1): 6767–6768.
https://doi.org/10.1182/blood-2022-162249
Published: 2022
Journal Articles

ASC4KIDS: A Multicenter, Open-Label, Phase Ib/II Study to Determine the Dose and Safety of Asciminib in Pediatric Patients with Chronic Myeloid Leukemia in Chronic Phase

Nobuko Hijiya, Shruti Kapoor, Matthias Hoch, Laurence Descamps, Kohinoor Dasgupta, Nicholas Ramscar
Journal: Blood
Blood (2022) 140 (Supplement 1): 12204–12205.
https://doi.org/10.1182/blood-2022-162451
Published: 2022
Journal Articles

Trial in Progress: A Multicenter, Open-Label, Phase Ib/II Study to Determine the Dose and Safety of Asciminib in Pediatric Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase Treated with ≥1 Prior Tyrosine Kinase Inhibitor

Nobuko Hijiya, Shruti Kapoor, Laurence Descamps, Mohamed Amine Bayar, Nicholas Ramscar
Journal: Blood
Blood (2021) 138 (Supplement 1): 2561.
https://doi.org/10.1182/blood-2021-151198
Published: 2021
Journal Articles

Trial in Progress: A Multicenter, Open Label, Randomized, Phase III Study of Asciminib (80 mg Once Daily) Vs Investigator-Selected TKI in Newly Diagnosed Adult Patients with Chronic Myeloid Leukemia in Chronic Phase

Jorge E. Cortes, Andreas Hochhaus, Naoto Takahashi, Richard A. Larson, Ghayas C. Issa, Felice Bombaci, Nicholas Ramscar, Shruti Kapoor, Sophie Ifrah, Timothy P. Hughes
Journal: Blood
Blood (2021) 138 (Supplement 1): 1478.
https://doi.org/10.1182/blood-2021-151239
Published: 2021
Journal Articles

Global Treatment Satisfaction Levels and Treatment Patterns from the International Sickle Cell World Assessment Survey (SWAY): Hydroxyurea (HU) Versus No HU

Fuad A El Rassi, MD, John James, MSc, Biree Andemariam, MD, Baba PD Inusa, MDMBBS, Beverley Francis-Gibson, MA, Alecia C Nero, MD, Caterina P Minniti, MD, Cassandra Trimnell, BA, Miguel R Abboud, MD, Jean-Benoît Arlet, MD, Raffaella Colombatti, MDPhD, Mariane de Montalembert, MD PhD, Suman Jain, MD, Wasil Jastaniah, MD, Erfan Nur, MD PhD, Marimilia Pita, MD, Nicholas Ramscar, MBBS, Tom Bailey, MSci, Olivera Rajkovic-Hooley, PhD, Ifeyinwa Osunkwo, MD MPH
Journal: Blood
Blood (2020) 136 (Supplement 1): 8–10.
https://doi.org/10.1182/blood-2020-137103
Published: 2020
Journal Articles

The Effect of Crizanlizumab on the Number of Days Requiring Opioid Use for Management of Pain Associated with Vaso-Occlusive Crises in Patients with Sickle Cell Disease: Results from the Sustain Trial

Wally R Smith, MD, Kenneth I. Ataga, MD, Santosh L. Saraf, MD, Olufolake A. Adisa, MDMSc, Miranda Bailey, Nicholas Ramscar, MBBS, Ashley Bonner, PhD, Stephen Brown, PhD, Laura Pastor, MSc
Journal: Blood
Blood (2020) 136 (Supplement 1): 32–33.
https://doi.org/10.1182/blood-2020-140428
Published: 2020
Journal Articles

An Age Analysis of the International Sickle Cell World Assessment Survey (SWAY), Focusing on Symptoms, Treatment Goals and the Impact of SCD on Patients' Daily Lives

Raffaella Colombatti, MDPhD, John James, MSc, Biree Andemariam, MD, Baba PD Inusa, MDMBBS, Fuad A El Rassi, MD, Beverley Francis-Gibson, MA, Alecia C Nero, MD, Caterina P Minniti, MD, Cassandra Trimnell, BA, Miguel R Abboud, MD, Jean-Benoît Arlet, MD, Mariane de Montalembert, MD PhD, Suman Jain, MD, Wasil Jastaniah, MD, Erfan Nur, MD PhD, Marimilia Pita, MD, Nicholas Ramscar, MBBS, Tom Bailey, MSci, Olivera Rajkovic-Hooley, PhD, Ifeyinwa Osunkwo, MD MPH
Journal: Blood
Blood (2020) 136 (Supplement 1): 3–5.
https://doi.org/10.1182/blood-2020-136073
Published: 2020
Journal Articles

A Patient-Centric Approach to Improve the Understanding of Sickle Cell Disease Using Real-World Data

E. Leila Jerome Clay, MD, Miranda Bailey, Dan Drozd, MD MSc, Jincy Paulose, MD, Nicholas Ramscar, MBBS, Kieran Mace, PhD, David Wormser, PhD MSc, MPhil
Journal: Blood
Blood (2020) 136 (Supplement 1): 27–28.
https://doi.org/10.1182/blood-2020-139148
Published: 2020
Journal Articles

Real World Use of Thrombopoietin-Receptor Agonists in the Management of Immune Thrombocytopenia in the United Kingdom: Results from the TRAIT Study

Nichola Cooper, MRCP, Andrew Provan, Marie Scully, MD MRCP, FRCPath, Henri Grech, Catherine Bagot, MD FRCPath, MBBS, Quentin A Hill, BSc, MBChB, MRCP, FRCPath, Tim Nokes, Nicholas Ramscar, Luke Saunders
Journal: Blood
Blood (2018) 132 (Supplement 1): 2426.
https://doi.org/10.1182/blood-2018-99-110126
Published: 2018